Masami Ukawa

584 total citations
25 papers, 481 citations indexed

About

Masami Ukawa is a scholar working on Molecular Biology, Immunology and Pharmaceutical Science. According to data from OpenAlex, Masami Ukawa has authored 25 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Pharmaceutical Science. Recurrent topics in Masami Ukawa's work include RNA Interference and Gene Delivery (15 papers), Immunotherapy and Immune Responses (7 papers) and Virus-based gene therapy research (4 papers). Masami Ukawa is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Immunotherapy and Immune Responses (7 papers) and Virus-based gene therapy research (4 papers). Masami Ukawa collaborates with scholars based in Japan, Egypt and United States. Masami Ukawa's co-authors include Tatsuhiro Ishida, Taro Shimizu, Hidenori Ando, Amr S. Abu Lila, Hidetaka Akita, Hideyoshi Harashima, Yu Ishima, Yosuke Hashimoto, Hiroshi Kiwada and Tomoya Masuda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Masami Ukawa

24 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masami Ukawa Japan	12	293	127	103	64	62	25	481
Zhenjia Wang United States	12	591 2.0×	142 1.1×	75 0.7×	110 1.7×	30 0.5×	26	848
Kentaro Hatanaka Japan	13	325 1.1×	277 2.2×	65 0.6×	130 2.0×	83 1.3×	20	588
Christina L. Parker United States	8	218 0.7×	178 1.4×	30 0.3×	108 1.7×	43 0.7×	11	428
Chenglong Ge China	13	366 1.2×	137 1.1×	107 1.0×	158 2.5×	41 0.7×	27	649
Aram Shajii United States	6	325 1.1×	161 1.3×	70 0.7×	211 3.3×	16 0.3×	6	573
Dipak S. Pisal United States	8	342 1.2×	153 1.2×	68 0.7×	70 1.1×	96 1.5×	12	600
Kelli M. Luginbuhl United States	10	373 1.3×	243 1.9×	45 0.4×	94 1.5×	48 0.8×	12	686
Tianjiao Chu China	9	164 0.6×	140 1.1×	73 0.7×	222 3.5×	29 0.5×	19	523
Jeffrey L. Schaal United States	9	192 0.7×	204 1.6×	50 0.5×	128 2.0×	20 0.3×	13	498

Countries citing papers authored by Masami Ukawa

Since Specialization

Citations

This map shows the geographic impact of Masami Ukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Ukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Ukawa more than expected).

Fields of papers citing papers by Masami Ukawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Ukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Ukawa. The network helps show where Masami Ukawa may publish in the future.

Co-authorship network of co-authors of Masami Ukawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Ukawa. A scholar is included among the top collaborators of Masami Ukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Ukawa. Masami Ukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ukawa, Masami, et al.. (2024). The Improved Antigen Uptake and Presentation of Dendritic Cells Using Cell-Penetrating D-octaarginine-Linked PNVA-co-AA as a Novel Dendritic Cell-Based Vaccine. International Journal of Molecular Sciences. 25(11). 5997–5997. 5 indexed citations

Fujimoto, Koichi, et al.. (2023). Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides. International Journal of Pharmaceutics. 647. 123499–123499. 4 indexed citations

Ukawa, Masami, et al.. (2022). Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer. Molecular Pharmaceutics. 20(1). 303–313. 6 indexed citations

Ukawa, Masami, et al.. (2022). Acquisition of absorption-enhancing abilities of cationic oligopeptides with short chain arginine residues through conjugation to hyaluronic acid. International Journal of Pharmaceutics. 616. 121519–121519. 6 indexed citations

Okamoto, Mariko, et al.. (2022). Evaluation of a <sub>D</sub>-Octaarginine-linked polymer as a transfection tool for transient and stable transgene expression in human and murine cell lines. Journal of Veterinary Medical Science. 84(4). 484–493. 3 indexed citations

Ukawa, Masami, Kohei Miyata, Etsuo Tobita, et al.. (2021). Mechanism on antigen delivery under mucosal vaccination using cell-penetrating peptides immobilized at multiple points on polymeric platforms. International Journal of Pharmaceutics. 613. 121376–121376. 2 indexed citations

Ukawa, Masami, et al.. (2020). Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine. European Journal of Pharmaceutics and Biopharmaceutics. 154. 186–194. 12 indexed citations

Ukawa, Masami, Yuki Yoshida, Kohei Miyata, et al.. (2019). Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses. Bioconjugate Chemistry. 30(12). 3028–3037. 9 indexed citations

Ukawa, Masami, Yuki Yoshida, Etsuo Tobita, et al.. (2019). Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination. Molecular Pharmaceutics. 16(3). 1105–1118. 17 indexed citations

10.

Mohri, Kohta, Masami Ukawa, Takaaki Eguchi, et al.. (2019). Tumor recognition of peanut agglutinin-immobilized fluorescent nanospheres in biopsied human tissues. European Journal of Pharmaceutics and Biopharmaceutics. 136. 29–37. 3 indexed citations

11.

Miyata, Kohei, Masami Ukawa, Kohta Mohri, et al.. (2018). Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery. Bioconjugate Chemistry. 29(5). 1748–1755. 15 indexed citations

12.

Pham, Wellington, Shawn Barton, Bo Li, et al.. (2018). Specific Molecular Recognition as a Strategy to Delineate Tumor Margin Using Topically Applied Fluorescence Embedded Nanoparticles. SHILAP Revista de lepidopterología. 1(3). 194–207. 1 indexed citations

13.

Lila, Amr S. Abu, et al.. (2017). Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity. Journal of Controlled Release. 250. 20–26. 47 indexed citations

14.

Shimizu, Taro, Amr S. Abu Lila, Yusuke Doi, et al.. (2017). Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model. Cancer Science. 108(9). 1864–1869. 21 indexed citations

15.

Ikeda, Mayumi, Yu Ishima, Victor Tuan Giam Chuang, et al.. (2017). Quantitative determination of polysulfide in albumins, plasma proteins and biological fluid samples using a novel combined assays approach. Analytica Chimica Acta. 969. 18–25. 33 indexed citations

16.

Shimizu, Taro, Yosuke Hashimoto, Masami Ukawa, et al.. (2015). Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells. Immunobiology. 220(10). 1151–1160. 72 indexed citations

17.

Ando, Hidenori, Sakiko Kobayashi, Amr S. Abu Lila, et al.. (2015). Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed. Journal of Controlled Release. 220(Pt A). 29–36. 30 indexed citations

18.

Ukawa, Masami, Hidetaka Akita, Yasuhiro Hayashi, et al.. (2014). Neutralized Nanoparticle Composed of SS‐Cleavable and pH‐Activated Lipid‐Like Material as a Long‐Lasting and Liver‐Specific Gene Delivery System. Advanced Healthcare Materials. 3(8). 1222–1229. 33 indexed citations

19.

Ukawa, Masami, Hidetaka Akita, Tomoya Masuda, et al.. (2010). 2-Methacryloyloxyethyl phosphorylcholine polymer (MPC)-coating improves the transfection activity of GALA-modified lipid nanoparticles by assisting the cellular uptake and intracellular dissociation of plasmid DNA in primary hepatocytes. Biomaterials. 31(24). 6355–6362. 42 indexed citations

20.

Masuda, Tomoya, Hidetaka Akita, Kenichi Niikura, et al.. (2009). Envelope-type lipid nanoparticles incorporating a short PEG-lipid conjugate for improved control of intracellular trafficking and transgene transcription. Biomaterials. 30(27). 4806–4814. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact